Patents by Inventor Adam Bunt

Adam Bunt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibacterial compounds
    Patent number: 11845725
    Abstract: This invention relates to compounds of formula (I) and methods of treatment using the compounds. The compounds of the invention can be used in combination with antibacterial agents to treat bacterial infections. More specifically, the compounds of formula (I) can be used in combination with a class of antibacterial agents known as carbapenems. The novel compounds of the present invention are enzyme inhibitors and more particularly are metallo-?-lactamase inhibitors.
    Type: Grant
    Filed: September 16, 2022
    Date of Patent: December 19, 2023
    Assignee: INFEX Therapeutics Limited
    Inventors: Ian Cooper, David Orr, Andrew Wilkinson, Jonathan Finlayson, Adam Bunt, Pia Appelqvist, Hans Wallberg, Fredrik Wångsell
  • SYNTHESIS OF PYRROLE ACID DERIVATIVES
    Publication number: 20230286915
    Abstract: This invention relates to the synthesis of compounds that can be used to treat bacterial infections in combination with other antibacterial agents, and more specifically in combination with a class of antibacterial agents known as carbapenems. The compounds resulting from the novel methods of the present invention are enzyme inhibitors and more particularly are metallo-?-lactamase inhibitors.
    Type: Application
    Filed: October 6, 2021
    Publication date: September 14, 2023
    Inventors: Andrew Wilkinson, lan Cooper, David Orr, Jonathan Finlayson, Adam Bunt, James Kirkham, David Lyth, Kevin Blades
  • ANTIBACTERIAL COMPOUNDS
    Publication number: 20230060011
    Abstract: This invention relates to compounds of formula (I) and methods of treatment using the compounds. The compounds of the invention can be used in combination with antibacterial agents to treat bacterial infections. More specifically, the compounds of formula (I) can be used in combination with a class of antibacterial agents known as carbapenems. The novel compounds of the present invention are enzyme inhibitors and more particularly are metallo-?-lactamase inhibitors.
    Type: Application
    Filed: September 16, 2022
    Publication date: February 23, 2023
    Inventors: Ian Cooper, David Orr, Andrew Wilkinson, Jonathan Finlayson, Adam Bunt, Pia Appelqvist, Hans Wallberg, Fredrik Wångsell
  • 1-AMINOSULFONYL-2-CARBOXYPYRROLE DERIVATIVES AS METALLO-BETA-LACTAMASE INHIBITORS
    Publication number: 20230018460
    Abstract: This invention relates to compounds of formula (I) and methods of treatment using the compounds. The compounds of the invention can be used in combination with antibacterial agents to treat bacterial infections. More specifically, the compounds of formula (I) can be used in combination with a class of antibacterial agents known as carbapenems. The novel compounds of the present invention are enzyme inhibitors and more particularly are metallo-?-lactamase inhibitors.
    Type: Application
    Filed: November 19, 2020
    Publication date: January 19, 2023
    Inventors: Andrew Wilkinson, Ian Cooper, David Orr, Jonathan Finlayson, Adam Bunt, Pia Appelqvist, Hans Wallberg, Fredrik Wångsell, James Kirkham
  • Antibacterial compounds
    Patent number: 11459296
    Abstract: This invention relates to compounds of formula (I) and methods of treatment using the compounds. The compounds of the invention can be used in combination with antibacterial agents to treat bacterial infections. More specifically, the compounds of formula (I) can be used in combination with a class of antibacterial agents known as carbapenems. The novel compounds of the present invention are enzyme inhibitors and more particularly are metallo-?-lactamase inhibitors.
    Type: Grant
    Filed: May 16, 2019
    Date of Patent: October 4, 2022
    Assignee: INFEX Therapeutics Limited
    Inventors: Ian Cooper, David Orr, Andrew Wilkinson, Jonathan Finlayson, Adam Bunt, Pia Appelqvist, Hans Wallberg, Fredrik Wångsell
  • Antibacterial Compounds
    Publication number: 20210230115
    Abstract: This invention relates to compounds of formula (I) and methods of treatment using the compounds. The compounds of the invention can be used in combination with antibacterial agents to treat bacterial infections. More specifically, the compounds of formula (I) can be used in combination with a class of antibacterial agents known as carbapenems. The novel compounds of the present invention are enzyme inhibitors and more particularly are metallo-?-lactamase inhibitors.
    Type: Application
    Filed: May 16, 2019
    Publication date: July 29, 2021
    Inventors: Ian Cooper, David ORR, Andrew Wilkinson, Jonathan Finlayson, Adam Bunt, Pia Appelqvist, Hans Wallberg, Fredrik Wångsell